Clinical trials for a CAR-T therapy, rap-cel, have been paused due to severe adverse events.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Clinical trials for a CAR-T therapy, rap-cel, have been paused due to severe adverse events.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Novartis
Swiss-American multinational pharmaceutical corporation